Published on February 13, 2026
Exhibit A
JOINT FILING AGREEMENT
The undersigned agree that this Schedule 13G Amendment No. 5 dated February 13, 2026 relating to the Common Stock, $0.001 par value, of Sutro Biopharma, Inc. shall be filed on behalf of the undersigned.
|
SUVRETTA CAPITAL MANAGEMENT, LLC
By: /s/ Andrew Nathanson | |
| Name: Andrew Nathanson | |
| Title: General Counsel and Chief Compliance Officer |
|
AVERILL MASTER FUND, LTD.
By: /s/ Andrew Nathanson | |
| Name: Andrew Nathanson | |
| Title: Authorized Signatory |
|
AARON COWEN
By: /s/ Aaron Cowen |